For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05966194
KEVLARx: A Randomized Placebo-Controlled Trial of Two Schedules of RRx-001 for the Attenuation of Severe Oral Mucositis in Patients Receiving Concomitant Chemoradiation for the Treatment of Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Contact Name:
Study Type:
Oncology - Head and Neck
Study Status:
Open to Accrual
Principal investigator:
Geoffrey Neuner, MD
IRB number :
2124031
Study Number:
K-01 (G2311)
Phone:
Fax:
LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Contact Name:
Kathryn Tower
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
1384014
Study Number:
LUNGMAP
Phone:
Fax:
Lungmap
NRG-BR007, "A Phase III Clinical Trial Evaluating DE-escalation of Breast RAdiation (DEBRA) for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer"
Contact Name:
Kathryn Tower
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Kruti Patel, MD
IRB number :
1773805
Study Number:
BR007
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04852887
NRG-BR008: A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO)
Contact Name:
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Geoffrey Neuner, MD
IRB number :
2042859
Study Number:
NRG-BR008
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05705401
NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Contact Name:
Study Type:
Oncology - Gastrointestinal
Study Status:
Open to Accrual
Principal investigator:
Gang Chen, MD, PhD
IRB number :
1928835
Study Number:
NRG-GI008
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05174169